Withdrawal of biologic therapy in juvenile idiopathic arthritis due to remission: predictors of flare and outcomes.

Ayşe Tanatar Özlem Akgün Şengül Çağlayan Esra Baglan Gülçin Otar Yener Kübra Oztürk Mustafa Cakan Hafize Emine Sönmez Betul Sozeri Nuray Aktay Ayaz

Published in: Expert opinion on biological therapy (2023)

When considering discontinuation of bDMARDs, it should be kept in mind that the risk of exacerbation requiring re-initiation therapy is quite significant within the first year after discontinuation of therapy.

Keyphrases

juvenile idiopathic arthritis
rheumatoid arthritis
chronic obstructive pulmonary disease
disease activity
stem cells
adipose tissue
intensive care unit
bone marrow
mesenchymal stem cells
cell therapy
weight loss
extracorporeal membrane oxygenation